Chris Vandepas
Director Portfolio Program Management
Guardant Health
Redwood City, United States
About me
My organisation
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, we're transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant Health has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext®, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal® for early-stage cancer patients. The Guardant Health screening portfolio, including the FDA-approved Shield™ test, aims to address the needs of individuals eligible for cancer screening.
Speaker sessions (2)
Thursday, 14 November 2024
16:00 - 16:30
PANEL DISCUSSION: Strategy formulation and alignment
- STRATEGIC ALLIANCES
Friday, 15 November 2024
12:00 - 12:30
PANEL DISCUSSION: Leveraging technologies for improved decision making
- DEEP DIVE INTO ARTIFICIAL INTELLIGENCE (AI), MACHINE LEARNING, AND PREDICTIVE ANALYTICS TO IMPROVE DECISION-MAKING